Stay updated with breaking news from Nautilus Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its rivals? We will compare Nautilus Biotechnology to similar businesses based on the strength of its earnings, institutional ownership, valuation, analyst recommendations, dividends, profitability and risk. Institutional & Insider Ownership […]
Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its rivals? We will compare Nautilus Biotechnology to related companies based on the strength of its profitability, earnings, analyst recommendations, valuation, dividends, risk and institutional ownership. Earnings and Valuation This table compares […]
Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) and Codex DNA (NASDAQ:DNAY – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, dividends, earnings and analyst recommendations. Profitability This table compares Nautilus Biotechnology and Codex DNA’s […]
Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it contrast to its peers? We will compare Nautilus Biotechnology to related companies based on the strength of its valuation, profitability, analyst recommendations, dividends, risk, institutional ownership and earnings. Institutional & Insider Ownership 47.9% of […]
Nautilus Biotechnology (NASDAQ:NAUT – Get Rating) and Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, profitability, risk, earnings, institutional ownership, analyst recommendations and dividends. Insider & Institutional Ownership 47.9% of Nautilus […]